% | $
Quotes you view appear here for quick access.

NIKE, Inc. Message Board

lukb4ujump 136 posts  |  Last Activity: Jul 19, 2016 10:38 AM Member since: Aug 10, 1999
  • lukb4ujump lukb4ujump Jul 1, 2016 11:38 AM Flag

    We get a new CEO, shortly after that we finally get a new CFO. And within the first few weeks, they put in a strategy and a cost savings plan and execute it immediately.

    Isn't this what we all were asking for the last 2 years? Someone to have a plan and execute on the plan?

    17 red thumbs from people who what? Wanted to keep burning valuable working capital with no end in sight? Having to dilute again and again?

    From Fortune Magazine.
    Layoffs are often a sign of failure by top executives to properly manage a business and forecast needs — and failure of board members to ensure that the right management is in place.

    The previous management refused to address or fix their mistakes so we brought in a new CEO and CFO who took care of it for them.

  • lukb4ujump lukb4ujump Jul 1, 2016 11:25 AM Flag

    Why don't you do the math? If 100 represents 73% of the workforce they are letting go, then solve for total number before and after layoffs.

  • lukb4ujump lukb4ujump Jul 1, 2016 11:21 AM Flag

    New CEO needs to be fully vested in his options before a sale...

  • Reply to

    WS not impressed

    by longs_r_losers Jun 30, 2016 6:16 PM
    lukb4ujump lukb4ujump Jun 30, 2016 7:28 PM Flag

    Those selling probably don't understand that the layoffs are to trim the fat and focus what is left on our resources on building shareholder value. In the past management spent money like drunken sailors, we burned through 500 million bucks and don't really have any new drugs to show for it... They took forever getting studies together and started. I am not sure what 300 plus employees did for their pay. Cindy is a prime example, she was worthless, what did she do in Switzerland managing the Eisai relationship? Eisai is in America and Japan...

  • We can't keep burning cash for drugs that are way out in the future. Focus on the drugs that have a great chance of success that are in the pipeline. We don't have the capital to try and discover new drugs every day, move 7 drugs through the pipeline and deal with Eisai.

    Bashers have been screaming cash burn and bad management. Now we get a guy in there that cuts costs, focuses on the drugs that will bring value to shareholders sooner and reduces the need to dilute in the near future. Buying us more time. I would have done this years ago, and my first lay off would have been Craig Audet that has done nothing for us in any way shape or form. In charge of global regulatory affairs and can't get a complete package to any of the other countries, refuses to hold the marketing partners to any standards. The guy is a total waste and so are most of the BODs.

  • Reply to

    ..... sysematic reversal .....

    by danindenver33 Jun 30, 2016 9:13 AM
    lukb4ujump lukb4ujump Jun 30, 2016 1:03 PM Flag

    For the record I am in the same boat, I was long the stock and was looking for great things. This is more then a disappointment for me as well, I am going through the anger stage as well. How could the results half way be so far off of the Phase II study. I was one that thought we would only get a go to completion, I was not in the camp of Halt for efficacy or halt for futility. And to see the drug arm performed worse then the Placebo is just crazy..

  • Reply to

    ..... sysematic reversal .....

    by danindenver33 Jun 30, 2016 9:13 AM
    lukb4ujump lukb4ujump Jun 30, 2016 12:52 PM Flag

    IDMC made a recommendation, not an order, not a decision. A recommendation based on their findings and stated with that recommendation that if unless their was a mistake or unless other data can be found that recommendation stands...

    Management could have released a PR stating the iDMC is recommending a halt for futility but we will investigate their decision and take the next 2 weeks to determine our path forward. That would have been within legal safe harbor, and left the door open to challenge the data and the decision. Giving up and throwing in the towel tells Me they were not surprised. Oh they say they are surprised because they have been milking this cow for years and saying anything else would mean they were pushing a fraud.

    Dan, what you did with my-gale was awesome and that was a great place to get additional information without all of the personal attacks. So thank you for that. If i may add, next time maybe you should have invited scientist from both sides of the argument. Because all of the Dr.'s you brought on were cheerleaders, smart cheerleaders but none the less they were all bullish and had all but guaranteed that a halt for futility was off the table.

  • Reply to

    ..... sysematic reversal .....

    by danindenver33 Jun 30, 2016 9:13 AM
    lukb4ujump lukb4ujump Jun 30, 2016 10:38 AM Flag

    Galena Biopharma (GALE) Receives IDMC Recommendation to Cease NeuVax Phase 3 Early Due to Futility
    IT was a recommendation not an order or a requirement. They could keep the trial going and investigate the findings. They could halt the study and investigate the findings. But they came out and stopped the study 2 days after they received the recommendation. They needed to make exit plans before they announced the halt.

  • Reply to

    ..... sysematic reversal .....

    by danindenver33 Jun 30, 2016 9:13 AM
    lukb4ujump lukb4ujump Jun 30, 2016 10:33 AM Flag

    Its OK Dan, Denial is the first of the five stages, denial, anger, bargaining, depression and acceptance are a part of the framework that makes up our learning to live with a loss.

    Soon you will get #$%$ and angry and so will everyone else, then the real damage will happen, the lawsuits will start to fly.

  • Reply to

    ..... sysematic reversal .....

    by danindenver33 Jun 30, 2016 9:13 AM
    lukb4ujump lukb4ujump Jun 30, 2016 10:27 AM Flag

    The company is a goner either way and you grasping for straws is not going to change it. Just a case of trying to read something into the tea leaves. Even management did not put up a fight, or say here are the results, we will look into the data and try and understand what happened. Nope they just came out and said, we are stopping the study...

  • Reply to


    by Jun 29, 2016 7:31 PM
    lukb4ujump lukb4ujump Jun 30, 2016 10:22 AM Flag

    The company at this point is dead either way. If the data is wrong then they will get sued for coming out and discontinuing the study without doing any investigation. If the IDMC findings are true then they have nothing to move forward with.

    A thought from my perspective is, look how quick management was to accept the findings and make their decision and to come right out and stop the trials without any fight or investigation. It is as though they knew it was going to happen and so they put up no fight. I don't think they were blind sided by the results. I think the disappointment is they will all have to go find new jobs and this cash cow will no longer be milked...

  • lukb4ujump lukb4ujump Jun 23, 2016 11:27 AM Flag

    Not a basher, I am long and have been. I have just been around the block a few times.. Did you see or predict the market destruction to .60? I did not... Before you call names lets see if the stock does in fact what I just said. Let that be my judge and jury and always remember that we are not always right in our thesis.

  • lukb4ujump lukb4ujump Jun 23, 2016 11:24 AM Flag

    Limit orders are for better pricing usually placed above the market.... at that price or better. Stop orders are placed below the market for a long or above the market for a short and is a trigger to protect from losses. It was protection, but with computers and visibility it became the guaranteed exit for the market manipulator.

  • lukb4ujump lukb4ujump Jun 23, 2016 11:18 AM Flag

    Not trying to correct you but this was in the press long ago.

    The NYSE has become the latest exchange to announce plans to no longer accept stop orders and good-till-canceled orders, beginning Feb. 26.

    NYSE joins the Nasdaq and BATS to announce such plans.

  • lukb4ujump lukb4ujump Jun 23, 2016 11:15 AM Flag

    I don't think so. I think we will now head down for a bit... Lower highs and lower lows last few days. Maybe even fill the gap. Then up going into the end of the month in anticipation of the findings. A go to completion is my bet and I for one do not think it will send the stock price wildly higher... That means we will need to survive for another 2 to 3 years waiting for the final event and the analysis of that event...

  • lukb4ujump lukb4ujump Jun 23, 2016 10:51 AM Flag

    Have you been paying attention?

    Stop orders are not allowed
    NYSE joining Nasdaq in eliminating stop orders - MarketWatch
    What To Do After NYSE Bans Stop Orders? - Smarter Analyst
    Why the SEC Really Pulled the Plug on Stops – and What You Can Do ..

    It was a great move, took away the bait and reason for stock raids. Visibility into the stop order book gave motive for the criminals to take stocks down. They knew shares were available at lower levels to fill all of the shorted stock to get to those lower levels.

  • Reply to

    Medical MJ story (Forbes)

    by bioimmunomabman Jun 21, 2016 10:31 AM
    lukb4ujump lukb4ujump Jun 21, 2016 3:26 PM Flag

    Was a good read.

  • lukb4ujump lukb4ujump Jun 20, 2016 11:53 AM Flag

    Eisai will get no other drugs from us. They control Belviq and that is it. In my mind ithat s questionable after we start getting more drugs through the pipe. We are stuck with those losers for a few more years. Once the CVOT is done, Arena will get more aggressive with them, I believe.

  • lukb4ujump lukb4ujump Jun 14, 2016 5:38 PM Flag

    Read my history, I am long.
    But this stock has not performed in any way shape or form as we longs have hoped. If you go way back, when this thing ran up I stated I would buy at 1.50. Got that chance and then it went to .60 out of no where.
    We (longs) got to bullish, we underestimated the shorts, the bashers and the bloggers. The market manipulation has been a major issue and lets not even talk about the low institutional participation rate in this stock. I have been in many stocks that Tutes did not own and they have always been able to acquire at the expense of retail through giant take downs through times of good news.

  • I believe we will be getting a go to completion. The big question becomes how long till the final event or the end of the last 2 and a half years. Then the time it takes to put the data together and release the results. Then the time it takes to prepare the NDA and the 9 months the FDA has to review the new drug app.

    What will the price of this stock do after the go to completion?
    A. Pop up a lot on good news but then get taken back down in anticipation of the 3 and a half plus years it will take to get to a new drug app.
    B. Pop up a little then back down because of cash burn issues? We have enough cash for 2 plus years before they need to raise.
    C. Start a 3 year run into a buyout / partnership and never look back. The best for us longs...
    D. A little blip and the same old market manipulation for another 2 years.
    E. Fill in the Blank with your thoughts.

    I have some friends that want to buy in and I really don't know what to tell them. The potential is huge but the pain could be more then they can handle... Especially if this gets taken back down in the low to mid 1's.

56.96-0.18(-0.32%)11:53 AMEDT